Cargando…

Recommendation of fiducial marker implantation for better target tracking using MV imager in prostate radiotherapy

PURPOSE: The aim of this study was to develop a model that optimizes the fiducial marker locations in the prostate to increase detectability of the markers in the projected EPID images during VMAT treatments. METHODS AND MATERIALS: The fiducial marker tracking capability for each arc was evaluated t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Ma, Tianjun, Kilian‐Meneghin, Joshua, Kumaraswamy, Lalith K.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	John Wiley and Sons Inc. 2018
Materias:	Radiation Oncology Physics
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6123135/ https://www.ncbi.nlm.nih.gov/pubmed/29947073 http://dx.doi.org/10.1002/acm2.12390

Ejemplares similares

Impact of prostate focused alignment on planned pelvic lymph node dose
por: Kilian‐Meneghin, Joshua, et al.
Publicado: (2021)

Retrospective analysis of MV–kV imaging‐based fiducial tracking in prostate SBRT treatment
por: Crotteau, Kevin, et al.
Publicado: (2022)

Carbon ion radiotherapy using fiducial markers for prostate cancer in Osaka HIMAK: Treatment planning
por: Tsubouchi, Toshiro, et al.
Publicado: (2021)

Detectability of fiducials’ positions for real‐time target tracking system equipping with a standard linac for multiple fiducial markers
por: Ono, Shunsuke, et al.
Publicado: (2020)

Improving fiducial and prostate capsule visualization for radiotherapy planning using MRI
por: Pathmanathan, Angela U., et al.
Publicado: (2019)

Investigation into the use of a MOSFET dosimeter as an implantable fiducial marker
por: Kry, Stephen F, et al.
Publicado: (2009)

Infections after fiducial marker implantation for prostate radiotherapy: are we underestimating the risks?
por: Loh, Jasmin, et al.
Publicado: (2015)

Prostate deformation during hypofractionated radiotherapy: an analysis of implanted fiducial marker displacement
por: Knybel, Lukas, et al.
Publicado: (2021)

Developing a MLC modifier program to improve fiducial detection for MV/kV imaging during hypofractionated prostate volumetric modulated arc therapy
por: Happersett, Laura, et al.
Publicado: (2019)

Clinical Implications of a Novel, Iron-containing Fiducial Marker in Radiotherapy for Liver Tumors: An Initial Experience
por: Doi, Hiroshi, et al.
Publicado: (2017)

Dose reduction potential of using gold fiducial markers for kilovoltage image‐guided radiotherapy
por: Takei, Yoshiki, et al.
Publicado: (2020)

Fiducial markers in prostate cancer image-guided radiotherapy
por: Ghaffari, Hamed, et al.
Publicado: (2019)

Comparison of kV Orthogonal Radiographs and kV-Cone-Beam Computed Tomography Image-Guided Radiotherapy Methods With and Without Implanted Fiducials in Prostate Cancer
por: Eren, Mehmet F, et al.
Publicado: (2020)

Using C‐Arm X‐ray images from marker insertion to confirm the gold fiducial marker identification in an MRI‐only prostate radiotherapy workflow
por: Gustafsson, Christian, et al.
Publicado: (2018)

Safety and efficacy of fiducial marker implantation for robotic stereotactic body radiation therapy with fiducial tracking
por: Scher, Nathaniel, et al.
Publicado: (2019)

Low Infection Rate After Transrectal Implantation of Gold Anchor ™ Fiducial Markers in Prostate Cancer Patients After Non-broad-spectrum Antibiotic Prophylaxis
por: Castellanos, Enrique, et al.
Publicado: (2018)

Accuracy of one algorithm used to modify a planned DVH with data from actual dose delivery
por: Ma, Tianjun, et al.
Publicado: (2016)

Comparison of low‐dose, half‐rotation, cone‐beam CT with electronic portal imaging device for registration of fiducial markers during prostate radiotherapy
por: Ung, Ngie Min, et al.
Publicado: (2013)

Percutaneous fiducial marker placement prior to stereotactic body radiotherapy for malignant liver tumors: an initial experience
por: Ohta, Kengo, et al.
Publicado: (2016)

Evaluation of computed tomography metal artifact and CyberKnife fiducial recognition for novel size fiducial markers
por: Nemoto, Hikaru, et al.
Publicado: (2023)

The impact of the three degrees‐of‐freedom fiducial marker‐based setup compared to soft tissue‐based setup in hypofractionated intensity‐modulated radiotherapy for prostate cancer
por: Tanabe, Satoshi, et al.
Publicado: (2019)

Potentials of on-line repositioning based on implanted fiducial markers and electronic portal imaging in prostate cancer radiotherapy
por: Graf, Reinhold, et al.
Publicado: (2009)

Effects of Gold Fiducial Marker Implantation on Tumor Control and Toxicity in External Beam Radiotherapy of Prostate Cancer
por: Moll, Matthias, et al.
Publicado: (2023)

Multiple Breath-hold Volumetric Modulated Arc Therapy Under Fluoroscopic Image Guidance with an Implanted Fiducial Marker: An Advanced Technique
por: Takanaka, Tsuyoshi, et al.
Publicado: (2018)

Utilization of cone‐beam CT for reconstruction of dose distribution delivered in image‐guided radiotherapy of prostate carcinoma — bony landmark setup compared to fiducial markers setup
por: Paluska, Petr, et al.
Publicado: (2013)

A collision prediction framework for noncoplanar radiotherapy planning and delivery
por: Islam, Naveed, et al.
Publicado: (2020)

Whole‐body dose equivalent including neutrons is similar for 6 MV and 15 MV IMRT, VMAT, and 3D conformal radiotherapy
por: Hauri, Pascal, et al.
Publicado: (2019)

Determination of optimal fiducial marker across image‐guided radiation therapy (IGRT) modalities: visibility and artifact analysis of gold, carbon, and polymer fiducial markers
por: Handsfield, Lydia L., et al.
Publicado: (2012)

Assessment of image quality and dose calculation accuracy on kV CBCT, MV CBCT, and MV CT images for urgent palliative radiotherapy treatments
por: Held, Mareike, et al.
Publicado: (2016)

Planning target volume margins for prostate radiotherapy using daily electronic portal imaging and implanted fiducial markers
por: Skarsgard, David, et al.
Publicado: (2010)

Monte Carlo calculation based on hydrogen composition of the tissue for MV photon radiotherapy
por: Demol, Benjamin, et al.
Publicado: (2015)

Fiducial markers visibility and artefacts in prostate cancer radiotherapy multi-modality imaging
por: Osman, Sarah O. S., et al.
Publicado: (2019)

Normal tissue doses from MV image‐guided radiation therapy (IGRT) using orthogonal MV and MV‐CBCT
por: Li, Yuting, et al.
Publicado: (2018)

Fiducial marker position affects target volume in stereotactic lung irradiation
por: Akasaka, Hiroaki, et al.
Publicado: (2022)

Intraprostatic Fiducials Compared with Bony Anatomy and Skin Marks for Image-Guided Radiation Therapy of Prostate Cancer
por: Moreau, Juliette, et al.
Publicado: (2017)

Intraprostatic fiducial markers: a potential application for ultrasound-guided radiotherapy in prostate cancer
por: Vavassori, A, et al.
Publicado: (2009)

Evaluation of gold fiducial marker manual localisation for magnetic resonance-only prostate radiotherapy
por: Maspero, Matteo, et al.
Publicado: (2018)

Cardiac embolization of an implanted fiducial marker for hepatic stereotactic body radiotherapy: a case report
por: Hennessey, Hooman, et al.
Publicado: (2009)

Accuracy of an MR-only workflow for prostate radiotherapy using semi-automatically burned-in fiducial markers
por: Goudschaal, Karin, et al.
Publicado: (2021)

Absence of prostate oedema obviates the need for delay between fiducial marker insertion and radiotherapy simulation
por: Patel, Deepti, et al.
Publicado: (2020)

Cannot write session to /tmp/vufind_sessions/sess_3bksat62378q64hvqgmf6rj12j